^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Neuroendocrine Tumor |
| Drug: | carboplatin (Tubulin polymerization promoter) + cabazitaxel (Microtubule inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Small cell/neuroendocrine prostate cancer...First-line and subsequent treatment options...Cabazitaxel/carboplatin
